01.01.07
National Bioscience Corp., Chester, NY, has been awarded a new patent, titled “Novel composition for the treatment of obesity and effective fat loss promotion.” The invention is related to a pharmaceutical composition for the treatment and management of obesity and comprises dihydroquercetin 3-rhamnoside and aralosides (Aralox). The composition of the present invention effectively promotes weight loss and body fat mass loss. Aralox is a dietary supplement that addresses weight loss through various metabolic pathways: activation of lipolytic processes, stimulation of hormone-sensitive lipase and the reduction of lipid droplets through the disruption of perilipins.